|
| Exchange Disseminated Time 30/07/2016 14:09:53 | Lincoln Pharmaceuticals Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on August 11, 2016 to consider and approve the Quarterly Unaudited Financial Results for the aforesaid quarter and also to consider any other business, if any.
In view of above, the trading window will remain dose for the Promoters, Directors, Insiders, Designated Persons and the Connected Persons from the date of this letter and shall reopen after the expiry of 48 hours from the time the result becomes generally available. |
|
|